Related Experiment Video
Updated: May 9, 2026
08:40
Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy
Published on: August 1, 2013
Tumor-altered dendritic cell function: implications for anti-tumor immunity.
1Hargadon Laboratory, Department of Biology, Hampden-Sydney College , Hampden-Sydney, VA , USA.
Frontiers in Immunology
|July 23, 2013
Summary
Tumor cells disrupt dendritic cell (DC) function, impairing anti-tumor immunity and immunotherapy efficacy. Understanding these DC alterations is crucial for developing strategies to enhance cancer immune responses.
Area of Science:
- Immunology
- Cancer Biology
- Cellular Immunology
Background:
- Dendritic cells (DCs) are crucial for initiating immune responses against pathogens and tumors.
- Tumor progression is often associated with impaired DC function, leading to immune evasion.
- Dysfunctional DCs impact both natural anti-tumor immunity and the effectiveness of DC-based immunotherapies.
Purpose of the Study:
- To review the mechanisms by which tumors alter DC function.
- To discuss the implications of tumor-altered DCs on anti-tumor immunity and immunotherapy.
- To identify unanswered questions and future research directions in this field.
Main Methods:
- Review of existing literature on DC function in cancer.
- Analysis of mechanisms underlying tumor-induced DC dysfunction.
- Discussion of the impact of altered DCs on the tumor microenvironment and immune response.
Main Results:
- Tumors inhibit DC differentiation and promote alternative cell fates (e.g., MDSCs, TAMs).
- Tumor microenvironments suppress DC maturation, activation, and function.
- Tumor-derived factors and cells induce immunoregulatory DCs, contributing to immune suppression.
Conclusions:
- Tumor-induced DC dysfunction is a significant barrier to effective anti-cancer immunity.
- Targeting tumor-altered DC pathways offers potential therapeutic strategies.
- Further research is needed to overcome DC dysfunction and enhance DC-mediated anti-tumor immunity.
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
01:22T Cell Activation and Clonal Selection
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
01:40Cell-mediated Immune Responses
Overview
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...